The Patent Finder

Grifols, S.A.

Also on record
Records under this name other than the patents Grifols, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 49 patents it holds.

Back to Grifols, S.A.

PatentTitleStatus Expires Confidence
US 9,482,679Composition for Use as an Abnormal Coagulation Control Plasma in in Vitro Assays
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,511,818Apparatus for Measuring the Optical Absorbency of Samples of Liquids, Method and Reaction Container for Its Implementation
Term ended
Term ended Nov 2, 2026 · High confidence
Term endedTerm ended Nov 2, 2026High confidence
US 9,844,548Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
Lapsed on the fee record
Ended Dec 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 19, 2025From the USPTO record
US 9,376,674Process to prepare a stable thrombin composition
Term ended
Term ended Oct 13, 2025 · From the USPTO record
Term endedTerm ended Oct 13, 2025From the USPTO record
US 7,291,595Use of ALPHA-1 Antitrypsin for the Preparation of Medicaments for the Treatment of Fibromyalgia
Term ended
Term ended Sep 19, 2025 · High confidence
Term endedTerm ended Sep 19, 2025High confidence
US 11,116,765Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Lapsed on the fee record
Ended Sep 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 14, 2025From the USPTO record
US 7,332,577Therapeutic Human Albumin Solutions with Low Prekallikrein Activator (PKA) Activity and Process for Obtaining Them
Term ended
Term ended Jul 19, 2025 · High confidence
Term endedTerm ended Jul 19, 2025High confidence
US 11,026,941Concentrated, inhalable ciprofloxacin formulation
Lapsed on the fee record
Ended Jun 8, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 8, 2025From the USPTO record
US 8,414,915Dual action, inhaled formulations providing both an immediate and sustained release profile
Lapsed on the fee record
Ended Apr 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 9, 2025From the USPTO record
US 9,545,401Concentrated, inhalable ciprofloxacin formulation
Lapsed on the fee record
Ended Jan 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2025From the USPTO record
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited